Podchaser Logo
Home
Vir Biotechnology: Tackling Infectious Disease

Vir Biotechnology: Tackling Infectious Disease

Released Thursday, 11th February 2021
Good episode? Give it some love!
Vir Biotechnology: Tackling Infectious Disease

Vir Biotechnology: Tackling Infectious Disease

Vir Biotechnology: Tackling Infectious Disease

Vir Biotechnology: Tackling Infectious Disease

Thursday, 11th February 2021
Good episode? Give it some love!
Rate Episode

Ηear from Dr. George Scangos, CEO of Vir Biotechnology, about how Vir combines immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases, one of the leading causes of death worldwide. Vir is tackling the world’s largest and most serious infectious diseases, infections that are evasive, challenging, or insufficiently addressed by current approaches, including hepatitis B, influenza A, SARS-CoV-2, HIV, and tuberculosis.

Speaker:

Dr. George Scangos, CEO, Vir Biotechnology & Former CEO, Biogen

Moderator:

Anna Protopapas, CEO Mersana Therapeutics

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features